๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Esophageal ulcer of Crohn's disease: Disappearance in 1 week with infliximab

โœ Scribed by Mitsuro Chiba; Takeshi Sugawara; Hidehiko Tsuda; Toru Abe; Takuo Tokairin; Yuji Kashima


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
90 KB
Volume
15
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Long-term outcome of maintenance inflixi
โœ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 218 KB ๐Ÿ‘ 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i

Mucosal healing predicts long-term outco
โœ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB ๐Ÿ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients